I have written a number of blogs and white papers on various aspects of healthcare and life expectancy, and a key focus of many of them has been the alarming rate of drug related fatalities in the U.S. In 2023, 110,000 people died from this cause representing about 3% of all deaths. While that is a small number compared to deaths from heart disease and cancer, overdoses were the leading cause of death for those in the 18-44 age group. Well, the great news is that the number of fatalities fell to roughly 80,000 in 2024, a decrease of just under 27%. We have now experienced sixteen months in a row of improvement!
Researchers remain cautious because they do not have a definitive explanation for this decrease, and there is always the possibility that the trend could reverse. In any case, the most commonly cited reasons for this welcome news are:
- There has been a massive public health response to the epidemic including improved access to addiction care, monitoring of overdose data, education of the public regarding the danger of opioids, and collaboration between public health agencies.
- Naloxone and other drugs that reverse an opioid overdose are increasingly available.
- There is evidence that a weaker form of fentanyl is being sold on the street.
- The waning of the Covid epidemic removes one source of stress that may have contributed to drug use.
- Unfortunately, the most vulnerable individuals have already died meaning those currently suffering from addiction have a better chance of not only surviving but recovering.
Now for the bad news. Apparently, President Trump views opioids largely as a law enforcement and border security issue. The budget bill passed by the House contains cuts of approximately $700 billion to Medicaid which provides roughly 21% of all spending on substance abuse prevention and treatment. Moreover, Secretary Kennedy has proposed reduction or elimination of a variety of programs that touch on some aspect of addiction. Of course, the budget now moves to the Senate where there are likely to be some changes. Nevertheless, researchers are very concerned that budget cuts may pause or even reverse the current positive momentum in dealing with the drug plague.